1. Akiguchi I, Kato T, Sugiyama H (1984) Trials of L-cysteine, TRH and 5-HTP in amyotrophic lateral sclerosis. Clin Neurol (Tokyo) 24: 1270–1273
2. Albers GW, Goldberg MP, Choi DW (1992) Do NMD A antagonists prevent neuronal injury? Yes. Arch Neurol 49: 418–420
3. Albin RL, Greenamyre JT (1992) Alternative excitotoxic hypotheses. Neurology 42: 733–738
4. Allaoua H, Chaudieu I, Krieger C et al. (1992) Alterations in spinal cord excitatory amino acid receptors in amyotrophic lateral sclerosis patients. Brain Res 579: 169–172
5. ALS CNTF Treatment Study (ACTS) Group (Brooks BR, Cedarbaum JM, Mitsumoto H, Neville H, Pestronk A 1992 ) A phase I ascending-dose tolerability and pharmacokinetic study of recombinant human ciliary neurotrophic factor (rHCNTF) in patients with amyotrophic lateral sclerosis (abstract). Neurology